Effect of treatment with ossein-hydroxyapatite compound on the time of fracture-healing.

Registry ID

EUCTR2010-020973-18

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

PIERRE FABRE MEDICAMENT

Start date

2011-03-01

Completion date

2012-06-20

Last update

2026-08-16

Conditions

• Wrist fracture

Summary

The main objective of this study is to compare the effect of a treatment with ossein-hydroxyapatite compound (L0006CP) versus a placebo on the time of fracture-healing in patients with a wrist fracture.

Locations

• , , Poland

View on source registry